#Canada #Calgary #Decibel Cannabis #AgMedica #Qwest

Decibel Cannabis Company Reports Impressive Revenue Growth in Q2 2025

Calgary, AB - August 21, 2025 - Decibel Cannabis Company Inc., recognized as a leading supplier of premium cannabis products, has unveiled its unaudited interim financial results for the second quarter of 2025. The figures demonstrate robust revenue growth and heightened profitability metrics, clearly signaling the company's upward trajectory in both domestic and international markets.

Record-Setting Second Quarter Performance

Decibel reported a net revenue of CAD 29.8 million for the closing quarter, representing a remarkable 35% increase year over year. This surge in revenue has its roots in significant contributions from AgMedica, specifically targeting international markets. The Canadian recreational sales saw a modest increase to CAD 23.7 million, attributed to successful marketing campaigns promoting the Qwest brand and the launch of new product lines including high-potency vapes and infused pre-rolls.

According to Benjamin Sze, CEO of Decibel, "Our second quarter was a turning point, characterized by our successful integration of AgMedica which greatly enhanced our international platform. As we progress through 2025, our goal remains focused on amplifying our presence in Canada while expanding into lucrative global markets."

Analyzing the Financial Highlights

Among the most notable financial achievements in Q2 were:

• - Net Canadian Recreational Sales: Reached CAD 23.7 million, up 7% compared to the previous year.
• - International Sales: Climbed significantly to CAD 6.1 million, marking a staggering quarter-over-quarter increase of 176% due to contributions from AgMedica.
• - Gross Margin: Improved to 47%, up from 42% year-over-year, demonstrating strengthened operational efficiencies.
• - Adjusted EBITDA: Rose to CAD 6.3 million, reflecting a 60% increase attributed to the growth in both international and net Canadian sales.
• - Free Cash Flow: Witnessed a substantial year-over-year increase of CAD 4.3 million, settling at CAD 2.2 million, underscoring efficient capital management.

Future Perspectives and Strategic Expansion

The figures reveal that Decibel's strategy to diversify and expand its market presence is paying off. The acquisition of AgMedica in late 2024 has fortified its capabilities, allowing Decibel to utilize an EU-GMP-certified facility that aligns with international standards. Sze noted, "The growing demand from international markets positions us favorably for projected incremental volumes and contracts in the latter half of 2025."

As Decibel looks to further increase its international footprint, the company has plans to roll out additional products and reinforce existing contracts while enhancing their marketing strategies. The leadership team is optimistic about the response their products have generated, indicating a promising future filled with growth opportunities.

Commitment to Quality and Innovation

Decibel Cannabis Company is a consumer-centric entity known for its commitment to high-quality cannabis products. With brands such as General Admission, Qwest, and Vox, Decibel not only holds a strong position within Canada but is also progressively establishing its presence globally. Its dedication to innovative product offerings ensures that it remains a preferred choice among consumers.

In conclusion, Decibel Cannabis Company is set on a robust growth trajectory, evidenced by its latest quarterly results. With strategic steps aimed at expansion and a firm commitment to quality, the organization is well-equipped to capitalize on the dynamic landscape of the cannabis industry. Following its momentum in Q2, Decibel is ready to take on the second half of the year with confidence, eager to further enhance its market share and profitability across both established and emerging markets.